HSPPC-96: a personalised cancer vaccine (Q34452027)

2 August 2017

1 reference

title

HSPPC-96: a personalised cancer vaccine (English)

1 reference

2 August 2017

Caudill MM

1

1 reference

2 August 2017

Li Z

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

1

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

539-547

1 reference

The makings of a tumor rejection antigen

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Tumor rejection antigens of chemically induced sarcomas of inbred mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Individually distinct transplantation antigens of chemically induced mouse tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Heat shock proteins transfer peptides during antigen processing and CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4(+) T cell independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

The dual nature of specific immunological activity of tumor-derived gp96 preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Immunotherapy of human cancer: lessons from mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.3.539

21 January 2018

Identifiers

DOI

10.1517/14712598.1.3.539

1 reference

2 August 2017

1 reference